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Introduction
Type-2 diabetes mellitus (DM) is characterized by inadequate insulin secretion and impaired insulin action (insulin resistance). Circulating cortisol levels are often normal in humans with DM or impaired glucose tolerance [1, 2] , but there is considerable evidence that glucocorticoids (GC) decrease insulin sensitivity [3] [4] [5] . Circulating GC concentrations alone may not reflect the concentration of cortisol in the target tissues of insulin (e.g. liver, adipose tissue and muscle). In fact, the tissue cortisol concentration is mainly controlled by two enzymes: 11β-hydroxysteroid dehydrogenase 1 (11β-HSD1) and 11β-hydroxysteroid dehydrogenase 2 (11β-HSD). 11β-HSD1 is NADP(H)-dependent and acts predominately as an oxo-reductase in vivo, generating the active cortisol from cortisone [6] . It potentiates the actions of GC in tissues and is widely distributed in the body with highest expression in liver and adipose tissue [7] . 11β-HSD2 utilizes NAD to inactivate cortisol to cortisone. It serves to protect the mineralocorticoid receptor (MR) from cortisol excess and is expressed in MR-rich tissues, such as kidney, colon and salivary glands [8, 9] . A pathogenetic role of 11β-HSD1 in insulin resistance is supported by several animal models. Mice overexpressing 11β-HSD1 developed obesity, DM and hyperlipidemia [10] . 11β-HSD1 knockout mice, however, showed resistance against the development of obesity and glucose tolerance and an increase in hepatic insulin sensitivity [11, 12] . In addition, selective inhibition of 11β-HSD1 in mice lead to increased glucose tolerance and insulin sensitivity and decreased body weight, cholesterol and triglycerides [13, 14] .
Type-2 DM is closely related to obesity [15, 16] . In both conditions, circulating triglycerides and free fatty acids (FFA) are frequently increased. Elevated FFAs induce peripheral and hepatic insulin resistance [17, 18] . Whether FFA-induced insulin resistance in humans is mediated by local elevated cortisol levels due to increased 11β-HSD1 activity was recently examined in two experiments. Acute hyperlipidemia, induced by 3-6 hours of lipid infusion, did not change hepatic 11β-HSD1 activity, but caused an increase in 11β-HSD1 activity in subcutaneous adipose tissue [19, 20] . The effect of prolonged lipid infusion over several days on 11β-HSD1 activity or expression has not been studied so far. Feline DM is an interesting model for human type-2 DM because it shows several pathophysiological similarities, including obesity-induced insulin resistance, impaired β-cell function, decreased number of β-cells and pancreatic amyloid deposition [21] [22] [23] . The aim of the present study was therefore to test whether prolonged lipid infusion in cats, with clamping of the triglyceride plasma concentration at the level found in untreated diabetic cats, has an influence on tissue cortisol metabolism; specifically we wanted to study whether lipid infusion affects 11β-HSD1, 11β-HSD2 and GC receptor expression in insulin sensitive tissues. Additionally, the influence of hyperlipidemia on plasma cortisol and leptin concentrations was evaluated.
Material and methods

Animals and infusions
Eleven healthy neutered male domestic short hair cats (Charles River, L'Arbresle, France) 15-18 months old (median 16 months) and weighing 3.4-4.8 kg (median 3.9 kg) were maintained at the animal care facility of the Clinic for Small Animal Internal Medicine, Vetsuisse Faculty, University of Zurich, Switzerland. Animal studies were approved by the Cantonal Veterinary Office of Zurich (permission nr. 51/2007). Cats were determined to be healthy on the basis of physical examination and clinical laboratory data; cats were at optimal body weight, based upon body condition (i.e., score 5/9 in all cats; Body Condition Score chart) [24] . They were fed twice/day with a commercial diet (PVD Feline DM Diet, Nestlé-Purina, St. Louis, MO, USA) given at a maintenance dose, and had free access to water.
For the experiment cats were randomly divided into two groups, housed in single cages and infused over 10 days through a jugular catheter. Group I (n=6) received a commercial lipid infusion (Lipovenoes 10%, Fressenius-Kabi, Bad Homburg, Germany). The lipid composition is provided in Table 1 . Blood triglyceride levels were measured two or three times daily to target levels at 3-7 mmol/l. Group II (n=5) served as control and was infused with saline at a maintenance rate (2 ml/kg/h).
Biochemical measurements
Plasma glucose was measured by a colorimetic hexokinase/glucose-6-phosphate dehydrogenase method, and triglycerides were measured by a colorimetric assay using glycerophosphate oxidase coupled to phenol and 4-aminophenazone (Roche, Vienna, Austria). Serum NEFAs were measured using the NEFA-C kit (Wako, Richmond, PA, USA).
A cross-reacting porcine insulin radioimmunoassay (Linco, St. Charles, MO, USA) was used to determine insulin concentrations [25] . Serum cortisol was measured by a chemiluminescence immunoassay (ADVIA Centaur ® System, Bayer (Schweiz) AG, Zurich, Switzerland) and leptin levels were determined by a radioimmunoassay (Linco, St. Charles, MO, USA) [26] .
Assessment of insulin sensitivity and tissue sample collection
During the 10-day infusion, overnight fasting blood samples were collected through the jugular catheter daily at 8:00 h to measure glucose and insulin. An intravenous glucose tolerance test (IVGTT) was performed under anesthesia in fasted cats 1 hour after the 10-day infusion. A glucose bolus of 1 g/kg was administered via the jugular catheter. Glucose and insulin were measured before the bolus and then at 5, 10, 15, 30, 45, 60, 90 and 120 minutes thereafter. The whole body insulin sensitivity index was calculated as described [27] . After IVGTT, cats were euthanized and tissue samples were collected within 30 minutes. Visceral (mesenteric) fat was collected adjacent to the jejunum, subcutaneous fat from the inguinal area, liver from the right caudal liver lobe and skeletal muscle from the vastus lateralis. The samples were immediately frozen into liquid nitrogen and stored at -80 ºC until further use.
RNA-isolation and cDNA synthesis
Total RNA from about 30 mg tissue was isolated using the RNeasy Mini kit (Qiagen, Basel, Switzerland). RNA was stored at -80 ºC until reverse-transcription (< 3 months). Negative controls containing only phosphate buffered saline (PBS 1×) were also co-extracted to monitor potential cross-contamination during the RNA isolation step. The purity and concentration of the extracted RNA was measured by optical density with a spectrophotometer (Nanodrop ND-100, Witec AG, Littau, Switzerland). A fixed amount (1 μg) of RNA was reverse-transcribed into cDNA. Genomic DNA was digested and RNA reverse-transcribed by the QuantiTect Reverse Transcription Kit (Qiagen). The cDNA was stored at -20 ºC (< 3 months).
Establishing and validation of the TaqMan ® real-time PCR assays
Probe and primer sequences for the TaqMan® fluorogenic real-time PCR assays were designed using PrimerExpress TM software (Version 2.0., Applied Biosystems, Rotkreuz, Switzerland) based on the feline 11β-HSD1 (AY496705), 11β-HSD2 (AY496706), GC receptor (DQ501388) and Leptin (AB041360) sequences deposited in the GenBank. For GAPDH a previously established system was used [28] . The primer and probe sequences are listed in Table 2 .
The specificity of the PCR primers was assessed by amplifying target DNA using the respective primer sets without probe. The PCR products of 11β-HSD1, 11β-HSD2, GC receptor and leptin were analyzed by gel electrophoresis, purified and sequenced as described elsewhere [29] . All four PCR systems produced a single band at the expected length.
Sequencing revealed identical nucleotide sequences compared to those for cats available in the public sequence database. 
Relative quantitation of mRNA expression
The relative quantification of expression of 11β-HSD1, 11β-HSD2, GC receptor and leptin was determined by real-time PCR using the comparative C T method [29] . In order to minimize variations all sequences of interest were amplified in parallel from of the same cDNA aliquot on the same plate.
Statistical analysis
Results were analyzed by non-parametric statistical methods (GraphPad Prism 4, San Diego, California, USA). Data are expressed as median and range. Body weight differences before and after infusion were compared using the Wilcoxon matched pairs test. Hormone and PCR results of lipid-and saline-infused cats were compared using the Mann-Whitney test.
Differences were considered significant at values of p < 0.05.
Results
Clinical course during the infusion experiment
The ten-day hyperlipidemic clamp was well tolerated in cats. The detailed clinical course (food intake, physical examination, electrolyte monitoring, blood glucose concentrations, plasma triacylglycerol concentrations) has been described by Zini et al. 2009 . After infusion, body weight decreased slightly in saline-infused cats (average difference: -4.3%) and increased significantly in lipid-infused cats (average difference: +10.7%, p< 0.05) ( Table 3) . 
Serum cortisol, leptin and NEFA concentrations at the end of the infusion period (
11β-HSD1, 11β-HSD2, GC receptor and leptin expression in different tissues
Subcutaneous adipose tissue (Figure 1)
Gene expression for 11β-HSD1 was significantly higher and that for GC receptor significantly lower in lipid-infused than in saline-infused cats (p<0.005, p<0.005 ). Levels of mRNA encoding 11β-HSD2 and leptin did not differ between the groups (not shown).
Visceral adipose tissue (Figure 2)
Gene expression for 11β-HSD1 was significantly higher, that for 11β-HSD2 and GC receptor significantly lower in lipid-infused than in saline-infused cats (p<0.005, p<0.005, p<0.005).
Levels of mRNA encoding leptin did not differ between the groups (not shown).
Liver (Figure 3)
Gene expression for 11β-HSD2 was significantly lower in lipid-infused than in saline-infused cats (p<0.005). Levels of mRNA encoding 11β-HSD1 and GC receptor did not differ between the groups (not shown). Leptin mRNA was not detectable in liver.
Skeletal muscle
There was no significant difference in gene expression for 11β-HSD1, 11β-HSD2, GC receptor or leptin between the groups (not shown).
Insulin sensitivity (Figure 4)
At day 10, the calculated whole body insulin sensitivity index of lipid-and saline-infused cats was not different.
Discussion
This is the first study evaluating the effects of prolonged lipid infusion on 11β-HSD expression in different tissues. The results show that 10-day hyperlipidemia leads to increased 11β-HSD1 expression in subcutaneous and visceral adipose tissue and decreased 11β-HSD2 expression in visceral adipose tissue and liver. 11β-HSD1 generates cortisol from cortisone, whereas 11β-HSD2 inactivates cortisol to cortisone [6, 7] . Up-regulation of 11β-HSD1 and down-regulation of 11β-HSD2 in adipose tissue therefore would be expected to lead to an increased tissue cortisol level. These results are in accordance with two studies in humans. In the first study, lipid infusion for 6 hours did not change hepatic and whole body 11β-HSD1
activity [19] . In the second study, however, lipid infusion for 3.5 hours induced a significant increase in 11β-HSD1 activity in the subcutaneous adipose tissue [20] .
The whole body insulin sensitivity of cats after 10 days of lipid infusion was not significantly different to that of the control cats. Importantly, one has to consider, that with the IVGTT we only measured the global insulin sensitivity of the body and not the individual insulin sensitivity of the adipose tissue or other organs. Because the main effects of hyperlipidemia seem to occur in the adipose tissue, it seems plausible to assume that, if adipose tissue insulin sensitivity had been measured separately, a difference in the insulin sensitivity between lipidinfused and saline-infused cats would have been detectable seems justifiable. Different from the result in cats, former studies in humans and rodents consistently showed an impairment of whole body insulin sensitivity following lipid infusion [30] [31] [32] [33] [34] [35] . Hence, it may be argued that the effect of hyperlipidemia on insulin sensitivity differs between cats and humans and rodents. It is, however, important to understand that, even though previously used emulsions were similar to ours, infusion times have been much shorter. Further, infusions were typically given at constant and relatively high rates. Experiments in humans and rodents have not been conducted to verify whether insulin sensitivity is still impaired after 10 days of lipid infusion in the diabetic range. It is therefore possible that lipid-induced insulin resistance, observed during short-term lipid infusion in humans and rodents, may no longer be present after 10-day infusion, due to some as yet unknown compensatory mechanisms.
In addition, to increased 11β-HSD1 and decreased 11β-HSD2 expression in adipose tissue, 10-day hyperlipidemia led to significantly decreased GC receptor expression. GC receptor expression has been shown to be inversely correlated with 11β-HSD1 expression, suggesting that compensatory autoregulation of this receptor might modulate the local effects of increased intra-adipose cortisol concentrations [36] . The importance of the GC receptor in the pathogenesis of insulin resistance, obesity and HC is emphasized by several rodent studies: in diabetic db/db mice and obese Zucker rats increased hepatic GC receptor mRNA expression caused hyperglycemia and insulin resistance. Conversely, selective inactivation of GC receptor improved insulin resistance and obesity in diabetic animals and patients with hypercortisolism [37] [38] [39] [40] . Therefore, one could argue that the decreased GC receptor expression seen in this study exhibits a self protecting mechanism of the tissue against the increased tissue cortisol.
Interestingly, the levels of GC receptor mRNA in cats did not differ between subcutaneous and visceral adipose tissue. This was also confirmed by examination of its expression in visceral and subcutaneous adipose tissue of 21 healthy cats [Sieber and Zini, unpublished data]. This finding differs from results from rodents and humans, where GC receptor mRNA levels were threefold higher in visceral compared to subcutaneous adipose tissue [10, 41] .
Enhanced GC receptor expression in visceral fat is discussed as one reason for an exaggerated accumulation of fat in this depot (visceral obesity) [10] . The different GC receptor mRNA expression in adipose tissue of cats could therefore fit to the finding that abdominal fat deposits in obese cats are equally distributed subcutaneously and intra-abdominally [42] .
Concerning body fat distribution, however, one has to consider the sexual status of an individual, as gonadal steroids are known to mediate body fat deposition [43, 44] . In this study and in the study of Hoenig et al. all cats were neutered; this could influence body fat distribution and possibly GC receptor expression.
Although considerable changes in 11β-HSD1, 11β-HSD2 and GC receptor expression were seen in lipid-infused cats, their serum cortisol concentrations at the end of the study did not differ from that of saline-infused cats. This suggests that the prolonged hyperlipidemia indeed influences the tissue cortisol metabolism but that the general cortisol secretion may not be influenced.
Serum leptin concentrations were significantly increased in lipid-infused cats compared to control cats. This is in accordance with results from rats, in which high-fat diets led to significantly elevated serum leptin concentrations and significant changes in body mass [38, 45] . Feeding a high-fat diet to cats induced a moderate but not significant elevation in leptin levels [26] . Leptin mRNA expression in adipose tissue did not correlate with serum leptin concentrations after 10 days of lipid infusion. Similarly, in cats fed ad libitum, tissue leptin mRNA expression did not change although blood leptin concentrations tended to increase with body weight gain [46] . This indicates that adipose tissue mRNA expression may not be indicative of plasma leptin concentrations in cats.
The results of this study point towards a possible connection between hyperlipidemia and tissue cortisol metabolism. Triglycerides and FFAs are frequently increased in obesity and type-2 DM and an induction of peripheral and hepatic insulin resistance by FFAs has been reported in humans [17, 18] . This study highlights one possible mechanism by which FFAs could influence tissue insulin sensitivity and the potential role of 11β-HSD1 in the pathophysiology of type-2 DM and obesity. Further studies in this field should substantiate the findings of this study and possibly focus on the influence of FFAs on other important enzymes that metabolize cortisol in tissues. Additionally, examination of 11β-HSD1 expression in adipose tissue and liver of obese cats, obese and insulin resistant cats and cats with DM could be of major interest and could lead to insights into the role 11β-HSD1 and tissue cortisol metabolism in insulin resistance and DM in cats.
A potential limitation of this study is the body weight gain during the experiment of the lipidinfused cats. In humans, obesity is associated with an increased 11β-HSD1 activity in the abdominal subcutaneous and visceral adipose tissue [47, 48] . Still it is unclear, if obesity is first and causes the increased 11β-HSD1 activity or if the increased 11β-HSD1 activity develops primarily and leads to obesity. That the increased body weight (and likely increased fat mass) had influenced the 11β-HSD1 expression in our study can't be completely excluded.
Future studies should address this issue by examining 11β-HSD1 expression during and after hyperlipidemia in animals with stable body weight.
In conclusion, a 10-day course of hyperlipidemia had a profound influence on 11β-HSD1, 11β-HSD2 and GC receptor expression in the subcutaneous and visceral adipose tissue of cats. Therefore, an association between hyperlipidemia and the tissue cortisol metabolism seems possible. Whole body insulin sensitivity Table 1 Fatty acid composition of Lipovenoes 10% (Fresenius-Kabi)
Fatty acid Percentage (%)
Linoleic acid 54
Linolenic acid 8
Oleic acid 26
Palmitic acid 9
Stearic acid 3 
